Stay updated on Upadacitinib vs Methotrexate in RA Clinical Trial
Sign up to get notified when there's something new on the Upadacitinib vs Methotrexate in RA Clinical Trial page.

Latest updates to the Upadacitinib vs Methotrexate in RA Clinical Trial page
- Check2 days agoChange DetectedRheumatoid arthritis is added as a topic and a related topic link to MedlinePlus Genetics appears; the page revision is updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedThe page no longer includes rheumatoid arthritis, related topics, or MedlinePlus Genetics sections.SummaryDifference0.1%

- Check30 days agoChange DetectedAdded related topics including Rheumatoid arthritis and MedlinePlus Genetics, and updated the revision to v3.5.0. Deleted the previous revision note v3.4.3.SummaryDifference0.1%

- Check38 days agoChange DetectedRevision: v3.4.3 updated from v3.4.2.SummaryDifference0.0%

- Check52 days agoChange DetectedRemoved the Related Topics entries for 'Rheumatoid arthritis' and 'MedlinePlus Genetics' (and the related topics heading) from the study page.SummaryDifference0.1%

- Check66 days agoChange DetectedRheumatoid arthritis and MedlinePlus Genetics topic links were added, and the page version updated from v3.4.1 to v3.4.2. These are minor metadata updates that do not modify the study content or user-facing details. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Upadacitinib vs Methotrexate in RA Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Upadacitinib vs Methotrexate in RA Clinical Trial page.